Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab in Adult Patients With Active Eosinophilic Esophagitis
NCT02379052Phase 2Completed
- Sponsor
- Regeneron Pharmaceuticals
- Start
- May 2015
- Primary completion
- Feb 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of dupilumab in eosinophilic esophagitis (EoE), sponsored by Regeneron Pharmaceuticals. Started May 2015; status: completed.
02
Drugs
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT02379052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02379052.